HIV-1 infection downregulates nuclear telomerase activity on lymphoblastoic cells without affecting the enzymatic components at the transcriptional level

AIDS Research and Human Retroviruses

Volumn 22, Issue 5, 2006, Pages 425-429

  Reynoso, R ^a   Minces, L ^a   Salomon, H ^a   Quarleri, J ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKEMIA CELL LINE; LYMPHOCYTE DEPLETION; LYMPHOID CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TELOMERE; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

CELL NUCLEUS; DOWN-REGULATION; HIV INFECTIONS; HIV-1; HUMANS; JURKAT CELLS; T-LYMPHOCYTES; TELOMERASE; TRANSCRIPTION, GENETIC;

EID: 33646860539     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2006.22.425     Document Type: Article

References (15)

1. Liu K, Hodes RJ, and Weng Np: Cutting edge: Telomerase activation in human T lymphocytes does not require increase in telomerase reverse transcriptase (hTERT) protein but is associated with hTERT phosphorylation and nuclear translocation. J Immunol 2001;166:4826-4830.
2. Vignoli M, Stecca B, Furlini G, Re MC, Mantovani V, Zauli G, Visani G, Colangeli V, and La Placa M: Impaired telomerase activity in uninfected haematopoietic progenitors in HIV-1-infected patients. AIDS 1998;12:999-1005.
3. Ballon G, Ometto L, Righetti E, Cattelan AM, Masiero S, Zanchetta M, Chieco-Bianchi L, and De Rossi A: Human immunodeficiency virus type 1 modulates telomerase activity in peripheral blood lymphocytes. J Infect Dis 2001;183:417-424.
4. + T cells. Cell Death Differ. 2004;11:782-784.
5. Vignoles M, Turk G, Minces L, Reynoso R, Saracco M, Salomón H, and Quarleri J: Telomerase activity remains unchanged after HIV-1 Tat expression in GHOST cells: Comparative analysis between HIV-1 subtype B and BF isolates [abstract WePe8.12B02], Presented at the 3rd IAS Conference on HIV Pathogenesis and Treatment, Rio de Janeiro, Brazil, July 2005.
6. Wu YY, Hruszkewycz AM, Delgado RM, Yang A, Vortmeyer AO, Moon YW, Weil RJ, Zhuang Z, and Remaley AT: Limitations on the quantitative determination of telomerase activity by the electrophoretic and ELISA based TRAP assays. Clin Chim Acta 2000;293:199-212.
7. Yi X, Shay JW, and Wright WE: Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells. Nucleic Acids Res 2001;29:4818-4825.
8. Cottliar A, Palumbo M, La Motta G, de Barrio S, Crivelli A, Viola M, Gomez JC, and Slavutsky I: Telomere length study in celiac disease. Am J Gastroenterol 2003;98:2727-2731.
9. Lin Z, Lim S, Viani MA, Sapp M, and Lim MS: Down-regulation of telomerase activity in malignant lymphomas by radiation and chemotherapeutic agents. Am J Pathol. 2001;159:711-719.
10. Colgin LM, Wilkinson C, Englezou A, Kilian A, Robinson MO, and Reddel RR: The hTERT α splice variant is a dominant negative inhibitor of telomerase activity. Neoplasia 2:426-432.
11. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, and Wright WE: Extension of life-span by introduction of telomerase into normal human cells. Science 1998;279:349-352.
12. Strahl C, and Blackburn EH: Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines. Mol Cell Biol 1996;16:53-65.
13. Effros RB: Replicative senescence: The final stage of memory T cell differentiation? Curr HIV Res 2003;1:153-165.
14. Bestilny LJ, Gill MJ, Mody CH, and Riabowol KT: Accelerated replicative senescence of the peripheral immune system induced by HIV infection. AIDS 2000;14:771-780.
15. Wolthers KC, Otto SA, Wisman GB, Fleury S, Reiss P, ten Kate RW, van der Zee AG, and Miedema F: Normal T-cell telomerase activity and upregulation in human immunodeficiency virus-1 infection. Blood 1999;93:1011-1019.